our products
our products

Call us at:



Click here to send us an email

Diagnostic Automation Question & AnswerDiagnostic Automation Question & Answer Diagnostic Automation Articles Diagnostic Automation kit images Diagnostic Automation videos

Pregnancy Rapid tests

Leptin ELISA kit


Leptin ELISA kit

Category Name Diabetes Assays ELISA kits
Test 96
Method ELISA method: Enzyme Linked Immunosorbent Assay
Principle ELISA principle: Solid phase enzyme linked immunosorbent assay
Detection Range 0-600 U/L
Sample 10ul
Specificity Not Observed
Sensitivity 4.6U/ml
Total Time ~90min
Shelf Life 12months

Item #:                    1742-6   Quantity:               

Leptin ELISA kit


Leptin ELISA kit

callback phone number email us

Leptin ELISA kit description:

The DAI Leptin Enzyme Immunoassay Kit provides materials for the quantitative determination of Leptin in serum and plasma. This ELISA testing kit is intended for in vitro diagnostic use only, except in the United States where it is intended for Research Use Only.

The Diagnostic Automation Leptin ELISA Kit is a solid phase enzyme-linked immunosorbent assay (ELISA) based on the sandwich principle. The microtiter wells are coated with a monoclonal antibody directed towards a unique antigenic site on a Leptin molecule. An aliquot of patient sample containing endogenous Leptin is incubated in the coated well with a specific rabbit anti Leptin antibody. A sandwich complex is formed.After incubation the unbound material is washed off and an anti rabbit peroxidase conjugate is added for detection of the bound Leptin. Having added the substrate solution, the intensity of color developed is proportional to the concentration of Leptin in the patient sample.

The disposal of the kit must be made according to the national regulations. Special information for this product is given in the Material Safety Data Sheets. In case of any severe damage of the test kit or components, DAI have to be informed written, latest one week after receiving the kit. Severely damaged single components should not be used for a test run. They have to be stored until a final solution has been found. After this, they should be disposed according to the official regulations.

Therapeutical consequences should never be based on laboratory results alone even if all test results are in agreement with the items as stated under point 10.1. Any laboratory result is only a part of the total clinical picture of a patient. Only in cases where the laboratory results are in acceptable agreement with the overall clinical picture of the patient should therapeutical consequences be derived. The test result itself should never be the sole determinant for deriving any therapeutical consequences.

Leptin diabetes test kit must be performed exactly as per the manufacturer’s instructions for use. Moreover the user must strictly adhere to the rules of GLP (Good Laboratory Practice) or other applicable national standards and/or laws. This is especially relevant for the use of control reagents. It is important to always include, within the test procedure, a sufficient number of controls for validating the accuracy and precision of the test. The test results are valid only if all controls are within the specified ranges and if all other test parameters are also within the given assay specifications. In case of any doubt or concern please contact DAI.
Product Note:

Our Leptin ELISA Kits are under the category of Diabetes Assay.